Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter
Regenerons $0.33 Billion Trading Day 287th in Activity as Sepsis Trial Advances and Eylea HD Approval Drive Mixed Investor Signals AInvest Source: Author: | Date: 2025-08-29 23:47:00 Source: Author: | Date: 2025-08-29 23:47:00
NK Insights: An Interactive Corneal Sensitivity Testing Workshop Ophthalmology Times Source: Author: | Date: 2025-08-29 20:13:00 Source: Author: | Date: 2025-08-29 20:13:00
Navigating the dangers of oculofacial surgery Ophthalmology Times Europe Source: Author: | Date: 2025-08-29 20:06:00 Source: Author: | Date: 2025-08-29 20:06:00
Ophthalmology Plans of Private Health Insurance Market to See Rapid Expansion | Humana, EyeBenefits openPR.com Source: Author: | Date: 2025-08-29 18:42:00 Source: Author: | Date: 2025-08-29 18:42:00
An artificial intelligence cloud platform for OCT-based retinal anomalies screening system in real clinical environments Nature Source: Author: | Date: 2025-08-29 17:34:00 Source: Author: | Date: 2025-08-29 17:34:00

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA; and John Hovanesian, MD, FACS; discuss the importance of comprehensive…

(Image Credit: AdobeStock) The recent OMEGA study1 found that “inferred sensitivity” mapping may be a potential functional surrogate end point for geographic atrophy (GA) based on its ability to predict retinal function with high spatial resolution and without extensive psychophysical…
Increased risk of dry eye disease observed in patients with diabetes: Study Medical Dialogues Source: Author: | Date: 2025-08-29 15:00:00 Source: Author: | Date: 2025-08-29 15:00:00
Dr. Ramu Gounder of Laurel Eye Clinic Brings Vision and Compassion to the Forefront exploreClarion Source: Author: | Date: 2025-08-29 14:35:00 Source: Author: | Date: 2025-08-29 14:35:00
FDA Dampens Outlook With Another Ophthalmic Bevacizumab CRL insights.citeline.com Source: Author: | Date: 2025-08-29 14:28:00 Source: Author: | Date: 2025-08-29 14:28:00